Physician profile
Melissa Arscott
NPI 1841290780
$358.79
in general payments reported to CMS, 2019-2025
11 companies · $46.16 in 2025
The $46.16 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.04 · 2020: $11.74 · 2021: $38.82 · 2022: $60.70 · 2023: $37.40 · 2024: $93.93 · 2025: $46.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $63.81 | 2019-2025 | Bexsero, Penmenvy |
| Cranial Technologies, INC | $61.64 | 2020-2023 | Doc Band |
| Pfizer INC. | $49.19 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $43.97 | 2024-2025 | Gardasil 9, Proquad, Gardasil |
| Ironshore Pharmaceuticals INC. | $29.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.89 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $19.67 | 2024 | Flumist Quadrivalent |
| Verrica Pharmaceuticals INC. | $18.31 | 2024 | Ycanth |
| Corium, LLC | $16.82 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Arscott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.